BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33879304)

  • 21. Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore.
    Chan A; Lew C; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
    Health Qual Life Outcomes; 2018 Jan; 16(1):20. PubMed ID: 29351803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testing the measurement invariance of the EORTC QLQ-C30 across primary cancer sites using multi-group confirmatory factor analysis.
    Costa DS; Aaronson NK; Fayers PM; Pallant JF; Velikova G; King MT
    Qual Life Res; 2015 Jan; 24(1):125-33. PubMed ID: 25193618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
    Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
    J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing quality of life in older adults: psychometric properties of the OPQoL-brief questionnaire in a nursing home population.
    Haugan G; Drageset J; André B; Kukulu K; Mugisha J; Utvær BKS
    Health Qual Life Outcomes; 2020 Jan; 18(1):1. PubMed ID: 31898546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Alzheimer's Disease on Caregiver Questionnaire: internal consistency, convergent validity, and test-retest reliability of a new measure for assessing caregiver burden.
    Cole JC; Ito D; Chen YJ; Cheng R; Bolognese J; Li-McLeod J
    Health Qual Life Outcomes; 2014 Sep; 12():114. PubMed ID: 25186634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients.
    Kontodimopoulos N; Ntinoulis K; Niakas D
    Eur J Cancer Care (Engl); 2011 May; 20(3):354-61. PubMed ID: 20345453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia.
    Gadisa DA; Gebremariam ET; Ali GY
    Health Qual Life Outcomes; 2019 Dec; 17(1):182. PubMed ID: 31830992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
    Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
    BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating patients for psychosocial distress and supportive care needs based on health-related quality of life in primary brain tumors: a prospective multicenter analysis of patients with gliomas in an outpatient setting.
    Hickmann AK; Hechtner M; Nadji-Ohl M; Janko M; Reuter AK; Kohlmann K; Haug M; Grüninger S; Deininger M; Ganslandt O; König J; Wirtz CR; Coburger J; Renovanz M
    J Neurooncol; 2017 Jan; 131(1):135-151. PubMed ID: 27638638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychometric evaluation of Azeri version of the head and neck cancer specific quality of life questionnaire (EORTC QLQ-H&N43).
    Davudov MM; Rahimov C; Harirchi I; Mirzajani Z; Amiraliyev N; Amiraliyev K; Rustamova N; Zebardast J; Montazeri A
    Health Qual Life Outcomes; 2020 Jul; 18(1):248. PubMed ID: 32703297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation study of the EORTC information questionnaire (EORTC QLQ-INFO25) in Iranian cancer patients.
    Asadi-Lari M; Ahmadi Pishkuhi M; Almasi-Hashiani A; Safiri S; Sepidarkish M
    Support Care Cancer; 2015 Jul; 23(7):1875-82. PubMed ID: 25475735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
    Araya LT; Gebretekle GB; Gebremariam GT; Fenta TG
    Health Qual Life Outcomes; 2019 Jan; 17(1):13. PubMed ID: 30642359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dimensionality and measurement invariance in the Satisfaction with Life Scale in Norway.
    Clench-Aas J; Nes RB; Dalgard OS; Aarø LE
    Qual Life Res; 2011 Oct; 20(8):1307-17. PubMed ID: 21308414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. International Psychometric Validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12).
    Weis J; Tomaszewski KA; Hammerlid E; Ignacio Arraras J; Conroy T; Lanceley A; Schmidt H; Wirtz M; Singer S; Pinto M; Alm El-Din M; Compter I; Holzner B; Hofmeister D; Chie WC; Czeladzki M; Harle A; Jones L; Ritter S; Flechtner HH; Bottomley A;
    J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28376231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor structure and measurement invariance of the Brief Symptom Inventory (BSI-18) in cancer patients.
    Calderon C; Ferrando PJ; Lorenzo-Seva U; Hernández R; Oporto-Alonso M; Jiménez-Fonseca P
    Int J Clin Health Psychol; 2020; 20(1):71-80. PubMed ID: 32021621
    [No Abstract]   [Full Text] [Related]  

  • 36. Psychometric properties of the EORTC Quality of Life Questionnaire in inpatient cancer rehabilitation in Germany.
    Dirmaier J; Zaun S; Koch U; Harfst T; Schulz H
    Palliat Support Care; 2004 Jun; 2(2):115-24. PubMed ID: 16594241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.
    El Alami Y; Essangri H; Majbar MA; Boutayeb S; Benamr S; El Malki HO; Souadka A
    BMC Cancer; 2021 Jan; 21(1):99. PubMed ID: 33499819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale.
    Hollen PJ; Gralla RJ; Kris MG; Cox C; Belani CP; Grunberg SM; Crawford J; Neidhart JA
    Cancer; 1994 Apr; 73(8):2087-98. PubMed ID: 8156514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.
    Koller M; Shamieh O; Hjermstad MJ; Hornslien K; Young T; Chalk T; Ioannidis G; Harle A; Johnson CD; Tomaszewski KA; Serpentini S; Pinto M; van der Weijst L; Janssens A; Morag O; Chie WC; Arraras JI; Pompili C; Jungraithmayr W; Hechtner M; Katsochi D; Müller K; Gräfenstein L; Schulz C; Bottomley A; ; ;
    Lancet Oncol; 2020 May; 21(5):723-732. PubMed ID: 32213338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The EORTC cancer in-patient satisfaction with care questionnaire: EORTC IN-PATSAT32 Validation study for Spanish patients.
    Arraras JI; Vera R; Martínez M; Hernández B; Laínez N; Rico M; Vila M; Chicata V; Asín G
    Clin Transl Oncol; 2009 Apr; 11(4):237-42. PubMed ID: 19380301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.